EIF2AK3 and neoplasm: Pharmacological (GSK2606414) or genetic inhibition of the PERK pathway in T cells was shown to preserve their energy reserves and enhance their anti-tumor effector functions, suggesting that targeting ER stress is a promising strategy to bolster T cell-mediated immunity (62).